Briacell Therapeutics
Price & Volume
Stats
See moreOpen | $3.87 |
Previous Close | $4 |
Day Range | $3.84-$3.88 |
52W Range | $3.60-$60.30 |
Market Cap | $28.2M |
Shares Short | 102,666 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$33.87 |
News
See moreYahoo Finance • 2 months ago
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Yahoo Finance • 3 months ago
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Yahoo Finance • 3 months ago
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
Yahoo Finance • 3 months ago
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
About
CEO | Dr. William V. Williams FCPA, M.D. |
CFO | Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. |
Address | Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
